DataMeds AI Shares Plunge After Launch of Health Lives Here Platform
DataMeds AI (MEDS) shares took an 11% hit on Monday after announcing its new health app, Health Lives Here. The platform focuses on individuals using GLP-1 medications and partners with Tollo Health.
The app connects users with credentialed physicians for virtual consultations and offers cash-payment alternatives for brand-name GLP-1 medications through Corexa's pharmacy division.
Health Lives Here also syncs with wearable devices, including Apple Watch and Samsung Galaxy Watch, and features an AI-powered health coaching system and activity tracking. A specialized AI chatbot monitors user communication and directs them to urgent assistance resources.
DataMeds AI plans to expand the platform's reach beyond GLP-1 medication users in 2026, targeting Long COVID patients first, followed by oncology patients in 2027. The company is also developing laboratory diagnostic services through its Helomics Corporation acquisition.